Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Harvard Business School
Federal Trade Commission
Covington
UBS
Argus Health
Moodys
Medtronic
Johnson and Johnson

Generated: April 25, 2018

DrugPatentWatch Database Preview

HYDROXYSTILBAMIDINE ISETHIONATE Drug Profile

« Back to Dashboard

When do Hydroxystilbamidine Isethionate patents expire, and what generic alternatives are available?

Hydroxystilbamidine Isethionate is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in HYDROXYSTILBAMIDINE ISETHIONATE is hydroxystilbamidine isethionate. Additional details are available on the hydroxystilbamidine isethionate profile page.
Summary for HYDROXYSTILBAMIDINE ISETHIONATE
Drug patent expirations by year for HYDROXYSTILBAMIDINE ISETHIONATE
Synonyms for HYDROXYSTILBAMIDINE ISETHIONATE
(4E)-4-[2-[4-(diaminomethylidene)cyclohexa-2,5-dien-1-ylidene]ethylidene]-3-oxocyclohexa-1,5-diene-1-carboximidamide
(4E)-4-[2-[4-(diaminomethylidene)cyclohexa-2,5-dien-1-ylidene]ethylidene]-3-oxocyclohexa-1,5-diene-1-carboximidamide; 2-hydroxyethanesulfonic acid
(4Z)-4-{2-[4-(diaminomethylidene)cyclohexa-2,5-dien-1-ylidene]ethylidene}-3-oxocyclohexa-1,5-diene-1-carboximidamide diisethionate
0163PVD2QZ
2-Hydroxy-4,4'-diamidinostilbene di(.beta.-hydroxyethanesulfonate)
2-Hydroxy-4,4'-diamidinostilbene di(beta-hydroxyethanesulfonate)
2-Hydroxy-4,4'-diguanylstilbene diisethionate
2-Hydroxy-4,4'-stilbenedicarboxamidine bis(2-hydroxyethanesulfonate) (salt)
2-hydroxy-4,4'-stilbenedicarboxamidine bis(2-hydroxyethanesulphonate) (salt)
2-Hydroxy-4,4'-stilbenedicarboxamidine di(.beta.-hydroxyethanes
2-Hydroxy-4,4'-stilbenedicarboxamidine di(.beta.-hydroxyethanesulfonate)
2-Hydroxy-4,4'-stilbenedicarboxamidine diisethionate
2-Hydroxyethanesulphonic acid, compound with 4-(2-(4-amidinophenyl)vinyl)-3-hydroxybenzenecarboxamidine (2:1)
2-Hydroxyethanesulphonic acid, compoundwith 4-(2-(4-amidinophenyl)vinyl)-3-hydroxybenzenecarboxamidine (2:1)
2-Hydroxystilbamidine diisethionate
2-Hydroxystilbamidine isethionate
4-[(E)-2-(4-carbamimidoylphenyl)vinyl]-3-hydroxy-benzamidine; 2-hydroxyethanesulfonic acid
495-99-8
533-22-2
AC1NUUQO
ACM495998
AKOS027382230
Benzenecarboximidamide, 4-(2-(4-(aminoiminomethyl)phenyl)ethenyl)-3-hydroxy-, bis(2-hydroxyethanesulfonate) (salt)
BRD-K62186992-334-01-0
CHEBI:135161
CHEMBL1200847
CHEMBL1301
CHEMBL2023895
D02RIV
DB01040
EINECS 208-557-3
Ethanesulfonic acid, 2-hydroxy-, compd. with 2-hydroxy-4,4'-stilbenedicarboxamidine (2:1)
Ethanesulfonic acid, 2-hydroxy-, compd. with 2-hydroxy-4,4'-stilbenedicarboxamidine (2:1) (8CI)
Ethanesulfonic acid, 2-hydroxy-, compd. with 4-(2-(4-(aminoiminomethyl)phenyl)ethenyl)-3-hydroxybenzenecarboximidamide (2:1)
Ethanesulfonic acid, 2-hydroxy-, compd. with 4-[(E)-2-[4-[amino(imino)methyl]phenyl]ethenyl]-3-hydroxybenzenecarboximidamide (1:1)
Ethanesulfonic acid, compd. with 2-hydroxy-4,4'-stilbenedicarboxamidine (2:1)
Ethanesulfonic acid, compd. with 4-[2-[4-(aminoiminomethyl)phenyl]ethenyl]-3-hydroxybenzenecarboximidamide (2:1)
FluoroGold (TN)
HMS2798D16
HSB
Hydroxystilbamide
HYDROXYSTILBAMIDINE
Hydroxystilbamidine diisethionate
hydroxystilbamidine hydrochloride
Hydroxystilbamidine isethionate [USP]
hydroxystilbamidine isetionate
MLS000756592
NSC 259242
NSC-259242
NSC259242
NSC646849
OR279754
OXISTILBAMIDINE ISETHIONATE
SCHEMBL108492
SCHEMBL554644
SCHEMBL8482349
SMR000449023
UNII-0163PVD2QZ

US Patents and Regulatory Information for HYDROXYSTILBAMIDINE ISETHIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us HYDROXYSTILBAMIDINE ISETHIONATE hydroxystilbamidine isethionate INJECTABLE;INJECTION 009166-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Covington
US Army
Queensland Health
Chubb
Chinese Patent Office
QuintilesIMS
Citi
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.